SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chern-En Chiang, Tzung-Dau Wang, Kwo-Chang Ueng, Tsung-Hsien Lin, Hung-I Yeh, Chung-Yin Chen, Yih-Jer Wu, Wei-Chuan Tsai, Ting-Hsing Chao, Chen-Huan Chen, Pao-Hsien Chu, Chia-Lun Chao, Ping-Yen Liu, Shih-Hsien Sung, Hao-Min Cheng, Kang-Ling Wang, Yi-Heng Li, Fu-Tien Chiang, Jyh-Hong Chen, Wen-Jone Chen, San-Jou Yeh, Shing-Jong Lin, 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension, Journal of the Chinese Medical Association, 2015, 78, 1, 1

    CrossRef

  2. 2
    William J. Elliott, Treatment, Journal of the American Society of Hypertension, 2015,

    CrossRef

  3. 3
    J Dingemanse, P Otasevic, K Shakeri-Nejad, E Klainman, B Putnikovic, H Kracker, M S Mueller, R Zimlichman, Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension, Journal of Human Hypertension, 2014,

    CrossRef

  4. 4
    Mohamed Haider, Magdy Mohamed, Muaadh Ali, Formulation and In vitro/In vivo Evaluation of Buccoadhesive Discs for Controlled Release of Calcium Channel Antagonist, American Journal of Drug Discovery and Development, 2014, 4, 4, 210

    CrossRef

  5. 5
    Renato Polimanti, Andrea Iorio, Sara Piacentini, Dario Manfellotto, Maria Fuciarelli, Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine, Pharmacogenomics, 2014, 15, 2, 157

    CrossRef

  6. 6
    Joshua K. Salabei, Daniel J. Conklin, Cardiovascular Autophagy: Crossroads of Pathology, Pharmacology and Toxicology, Cardiovascular Toxicology, 2013, 13, 3, 220

    CrossRef

  7. 7
    Hardik Gandhi, Vaibhav B. Patel, Nirav Mistry, Naeem Patni, Jatin Nandania, Ramachandran Balaraman, Doxorubicin mediated cardiotoxicity in rats: Protective role of felodipine on cardiac indices, Environmental Toxicology and Pharmacology, 2013, 36, 3, 787

    CrossRef

  8. 8
    Yu jun Li, Chu zhi Pan, Zi wen Zhao, Zhu xiang Zhao, Hui ling Chen, Wei bo Lu, Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China, BMC Infectious Diseases, 2013, 13, 1, 548

    CrossRef

  9. 9
    Kimberly A. Henderson, R. Brandon Borders, John B. Ross, Theresa B. Huwar, Calvin O. Travis, Brandon J. Wood, Zhenxu J. Ma, S. Peter Hong, Thomas M. Vinci, Brian M. Roche, Effects of tyrosine kinase inhibitors on rat isolated heart function and protein biomarkers indicative of toxicity, Journal of Pharmacological and Toxicological Methods, 2013, 68, 1, 150

    CrossRef

  10. 10
    Yoshiyuki Kubo, Yusuke Kusagawa, Masanori Tachikawa, Shin-ichi Akanuma, Ken-ichi Hosoya, Involvement of a Novel Organic Cation Transporter in Verapamil Transport Across the Inner Blood-Retinal Barrier, Pharmaceutical Research, 2013, 30, 3, 847

    CrossRef

  11. 11
    J. Hoyer, Nichtmedikamentöse und medikamentöse Therapie bei arterieller Hypertonie, Der Kardiologe, 2013, 7, 5, 352

    CrossRef

  12. 12
    Leandro Bueno Bergantin, Cláudio Fontes Souza, Regiane Miranda Ferreira, Soraya Soubhi Smaili, Neide Hyppolito Jurkiewicz, Afonso Caricati-Neto, Aron Jurkiewicz, Novel model for “calcium paradox” in sympathetic transmission of smooth muscles: Role of cyclic AMP pathway, Cell Calcium, 2013, 54, 3, 202

    CrossRef

  13. 13
    Wei Zheng, Natasha Thorne, John C. McKew, Phenotypic screens as a renewed approach for drug discovery, Drug Discovery Today, 2013, 18, 21-22, 1067

    CrossRef

  14. 14
    Rong Chen, Su-lan Zou, Ming-li Wang, Yan Jiang, Hui Xue, Chun-yan Qian, Zong-ling Xia, Population pharmacokinetics of digoxin in elderly patients, European Journal of Drug Metabolism and Pharmacokinetics, 2013, 38, 2, 115

    CrossRef

  15. 15
    Niels Decher, Michael F. Netter, Anne K. Streit, Putative Impact of RNA Editing on Drug Discovery, Chemical Biology & Drug Design, 2013, 81, 1
  16. 16
    Eija Junttila, Maarika Vaara, Juha Koskenkari, Pasi Ohtonen, Ari Karttunen, Pekka Raatikainen, Tero Ala-Kokko, Repolarization Abnormalities in Patients with Subarachnoid and Intracerebral Hemorrhage, Anesthesia & Analgesia, 2013, 116, 1, 190

    CrossRef

  17. 17
    Michio Fujisawa, Ryosuke Yorikane, Yuko Matsuoka, Hiroyuki Koike, Koichi Ueno, The Pharmacological Differences in Antianginal Effects of Long-lasting Calcium Channel Blockers, Journal of Cardiovascular Pharmacology, 2013, 61, 1, 63

    CrossRef

  18. 18
    Ignacio Pérez-Victoria, Jesús Martín, Víctor González-Menéndez, Nuria de Pedro, Noureddine El Aouad, Francisco Javier Ortiz-López, José Rubén Tormo, Gonzalo Platas, Francisca Vicente, Gerald F. Bills, Olga Genilloud, Michael A. Goetz, Fernando Reyes, Isolation and Structural Elucidation of Cyclic Tetrapeptides fromOnychocola sclerotica, Journal of Natural Products, 2012, 75, 6, 1210

    CrossRef

  19. 19
    M. O. Hegazi, G. Aldabie, S. Al-Mutairi, A. El Sayed, Junctional bradycardia with verapamil in renal failure – care required even with mild hyperkalaemia, Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 6
  20. 20
    Kenia Pedrosa Nunes, Hicham Labazi, R. Clinton Webb, New insights into hypertension-associated erectile dysfunction, Current Opinion in Nephrology and Hypertension, 2012, 21, 2, 163

    CrossRef

  21. 21
    J. Hoyer, Nichtmedikamentöse und medikamentöse Therapie bei arterieller Hypertonie, Herz, 2012, 37, 7, 728

    CrossRef

  22. You have free access to this content22
    Keith C. Ferdinand, A Compendium of Antihypertensive Therapy, The Journal of Clinical Hypertension, 2011, 13, 9
  23. 23
    Yuanjing Chen, Zhiyu Fan, Hanmin Liu, Calcium channel blockers for pulmonary arterial hypertension, The Cochrane Library,
  24. 24
    Niousha Ghamami, Sandy Hsiang Yu Chiang, James M Wright, Time course for blood pressure lowering of dihydropyridine calcium channel blockers, The Cochrane Library,
  25. 25
    Niousha Ghamami, Sandy Hsiang Yu Chiang, Colin Dormuth, James M Wright, Time course for blood pressure lowering of dihydropyridine calcium channel blockers, The Cochrane Library,